TEMPUS
Dr. Kim Blackwell
Kim Blackwell, MD is Chief Medical Officer at Tempus.
Check out the information below and if you are interested in booking time with her for a media interview or speaking opportunity, please contact us and we’ll get you connected.
Impressive
Background.
Dr. Kim Blackwell serves as Tempus’ Chief Medical Officer. She joins Tempus from Eli Lilly, where she was Vice President of Early Phase Oncology and Immuno-oncology.
Prior to that, she was a Professor of Medicine and Assistant Professor of Radiation Oncology at Duke University, where she directed the Women’s Cancer Program, Strategic Collaborations, and the Precision Medicine Initiative for the Duke Cancer Institute.
Making Headlines.
Fierce Healthcare: Tempus picks up CRO Highline Sciences as the precision medicine company expands its healthcare ambitions
HIT Consultant: GSK Launches Accelerated Clinical Trial with Tempus
Fierce Biotech: Janssen taps Tempus' AI and real-world data library for cancer drug discovery
Schedule Time.
If you are interested in scheduling Kim for a media interview or wish to have her speak at your event, let us know and we’ll get you connected.